SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : ASML Holding NV
ASML 396.03+0.4%3:59 PM EDT

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: BeenRetired5/29/2020 9:43:34 AM
   of 13879
 
"Carprofen and Celecoxib can inhibit the replication of COVID-19"...

These two drugs can stop the coronavirus from replicating
Jak Connor
May 29, 2020 at 2:31 am CDT

Scientists from around the world are in a constant race to figure out a treatment for the coronavirus that has taken the world by storm.Luckily, almost every day, steps are being made to understanding the virus more and also drugs that can interact with it. URV's Cheminformatics and Nutrition research group has conducted a study that included computational screening to predict whether or not there is a drug out there that can inhibit the replication of the virus.The study says that a human and a veterinary anti-inflammatory drug called Carprofen and Celecoxib can inhibit the replication of COVID-19 by targeting the main protease of the virus (M-pro). The study analyzed 6,466 drugs authorized by various drug agencies and found that 7 of them had the capabilities of inhibiting M-pro. If you are interested in reading more about this study, check out this link here for more information.
Read more: tweaktown.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext